OrbiMed Capital GP V LLC's Net Worth

$0

Estimate Recalculated Sep 12, 2024 05:02PM EST

Who is OrbiMed Capital GP V LLC?

OrbiMed Capital GP V LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., RHYTHM PHARMACEUTICALS, INC., PMV Pharmaceuticals, Inc., SI-BONE, Inc., Intellia Therapeutics, Inc., Inspire Medical Systems, Inc., Aadi Bioscience, Inc., Tricida, Inc., Adaptimmune Therapeutics PLC, ARMO BioSciences, Inc., Loxo Oncology, Inc., Nabriva Therapeutics AG, Dimension Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Compass Therapeutics, Inc., and Corvus Pharmaceuticals, Inc..

SEC CIK

OrbiMed Capital GP V LLC's CIK is 0001615374

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adicet Bio, Inc. (ACET) Snapshot price: $1.56

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.01%
3.13M
$2.40
$7,500,000.00
9.77M
Jan 25
Form 4
+12.10%
875K
$2.09
$1,828,750.00
8.11M
Jun 27
Form 4
+765.30%
214.28K
$14.00
$2,999,990.00
242.28K
Dec 10
Form 4
+10.25%
524.35K
$13.00
$6,816,537.00
5.64M
Feb 12
Form 4
∞
6.02M
—
—
6.02M
Sep 15 - Sep 17
Form 3
—
0
—
—
0
No matching records found

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.71%
-19.58K
$30.43
-$595,768.40
2.75M
May 22
Form 4
-4.54%
-131.64K
$30.88
-$4,065,439.72
2.77M
May 18 - May 21
Form 4
∞
2.9M
$17.00
—
2.9M
Oct 10
Form 3
—
0
—
—
0
No matching records found

PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-87.79K
$2.23
-$195,762.78
0
Nov 22
Form 4
-23.02%
-26.25K
$15.93
-$418,210.29
87.79K
May 26
Form 4
-100.00%
-474.50K
$21.63
-$10,264,415.00
0
Mar 29 - Mar 31
Form 4
∞
7.06M
$18.00
$8,550,000.00
7.06M
Sep 25 - Sep 29
Form 3
—
0
—
—
0
No matching records found

SI-BONE, Inc. (SIBN) Snapshot price: $15.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
985.37K
$15.00
—
985.37K
Oct 19
Form 3
—
0
—
—
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $19.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.66M
$18.00
—
2.66M
May 11
Form 3
—
0
—
—
0
No matching records found